Population
219 children and adolescents with synovial sarcoma
Design
Cohort
Follow-up
median 6.6 years (range, 0.5 to 30.7 years)
Authors
Loading...
Identifies high-risk subgroups with poor survival; hypothesis-generating for risk-stratified trials but should not yet change practice.
Clinical group, tumor size, and invasiveness are important prognostic factors for overall survival in children and adolescents with synovial sarcoma.
Okcu et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: